Le Lézard
Classified in: Health, Science and technology, Business
Subject: DIV

Avantor® Declares Dividend on Mandatory Convertible Preferred Stock


RADNOR, Pa., Jan. 21, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE:  AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on February 15, 2020 to holders of record on February 1, 2020.

About Avantor 
Avantor® is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.

Forward-Looking and Cautionary Statements

This press release contains, and oral statements made from time to time by Avantor's representatives may contain, "forward-looking statements."  Forward-looking statements include statements regarding the proposed public offerings and other statements identified by words such as "could," "may," "might," "will," "likely," "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "continues," "projects" and similar references to future periods, or by the inclusion of forecasts or projections. Forward-looking statements are based on Avantor's current expectations and assumptions regarding capital market conditions Avantor's business, the economy and other future conditions.  Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict.  As a result, Avantor's actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions, Avantor's ability to anticipate consumer demand; changes in consumer confidence and spending; Avantor's competitive environment and other factors set forth under "Risk Factors" in Avantor's prospectuses filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on May 20, 2019.  Any forward-looking statement made in this press release speaks only as of the date on which it is made.  Avantor undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

Media Contact 
Allison Hosak
Senior Vice President, Global Communications
Avantor
+1 610.573.2661
[email protected]

Investor Relations Contact 
Helen O'Donnell
Managing Director
Solebury Trout
+1 203.428.3213
[email protected] 

SOURCE Avantor and Financial News


These press releases may also interest you

at 06:25
Johnson & Johnson today announced results for first-quarter 2024. "Johnson & Johnson's solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline," said Joaquin Duato, Chairman and Chief Executive...

at 06:20
The new research gives a complete picture of the Chagas Disease: American trypanosomiasis market. It looks at trends in the CD market, including how common it is in different regions, and talks...

at 06:00
Stork Club, a pioneering enterprise reproductive care benefits solution, announced today that employers and their covered employees with Stork Club global coverage can now access care in 100 countries, in addition to the U.S.,...

at 06:00
Xstim, Inc., a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, is thrilled to announce its recent Premarket Application (PMA) approval from the U.S. Food and Drug Administration (FDA) for Xstimtm Spine Fusion...

at 05:30
Alcohol Justice Executive Director Cruz Avila, and Advocacy Director Raul Verdugo will be participating along with former Alcohol Justice Board Chair Richard Zaldivar in the 23rd Annual UCLA Kaiser Permanente Equity Symposium....

at 05:30
Nutex Health Inc. ("Nutex Health" or the "Company") , a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks,...



News published on and distributed by: